<DOC>
	<DOCNO>NCT00392587</DOCNO>
	<brief_summary>The purpose study assess safety GW856553 COPD patient assess affect COPD disease 14 day .</brief_summary>
	<brief_title>A Study To Investigate The Effects Of GW856553 On Patients With COPD ( Chronic Obstructive Pulmonary Disease )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Inclusion criterion : Women childbearing potential Established history COPD Cigarette smoke history great 10 pack year FEV1 40 80 % predict normal height , age sex . Exclusion criterion : Morbidly obese patient ( body mass index &gt; 40 ) Hospitalisation treatment worsen COPD past 6 week History increase liver function test hypersensitivity salbutamol ipratropium bromide Blood pressure &gt; 155/95</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Tolerability</keyword>
	<keyword>COPD</keyword>
	<keyword>Safety</keyword>
</DOC>